New positive inotropic agents: Advantages and disadvantages
- 1 January 1986
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- MDL 17,043: Short- and long-term cardiopulmonary and clinical effects in patients with heart failureJournal of the American College of Cardiology, 1985
- Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.Circulation, 1985
- Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failureAmerican Heart Journal, 1984
- Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failureJournal of the American College of Cardiology, 1984
- Pharmacology and inotropic potential of forskolin in the human heart.Journal of Clinical Investigation, 1984
- High prevalence of nonsustained ventricular tachycardia in severe congestive heart failureAmerican Heart Journal, 1984
- Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failureThe American Journal of Cardiology, 1983
- Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.Circulation, 1980
- Reduction of Digitalis Toxicity by Computer-Assisted Glycoside Dosage RegimensAnnals of Internal Medicine, 1972
- Cardiovascular Effects of Glucagon in ManNew England Journal of Medicine, 1968